Japanese drugmaker Eisai, which operates a dementia-focused research facility in Cambridge, is hoping to tap into Greater Boston's biotech startup community to complement its neurological research and drug development. Eisai is teaming up with BioLabs — a network of shared laboratory and office spaces that includes Cambridge-based LabCentral — to launch "Eisai Innovation Center BioLabs," an incubator designed to support local startups focused on neurology. The incubator is housed within Eisai's Center for Genetics Guided Dementia Discovery, a 50,000-square-foot facility inside the Alewife Research Center that opened in 2019.
Comments